Merck KGaA (LON:0O14)

London flag London · Delayed Price · Currency is GBP · Price in EUR
111.35
+0.30 (0.27%)
At close: Aug 13, 2025
-32.88%
Market Cap 41.68B
Revenue (ttm) 18.19B
Net Income (ttm) 2.45B
Shares Out n/a
EPS (ttm) 5.65
PE Ratio 16.98
Forward PE 12.72
Dividend 1.87 (1.73%)
Ex-Dividend Date Apr 28, 2025
Volume 5,346
Average Volume 36,359
Open 112.00
Previous Close 111.05
Day's Range 110.10 - 112.00
52-Week Range 100.90 - 176.85
Beta 0.63
RSI 52.68
Earnings Date Aug 7, 2025

About Merck KGaA

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company’s Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector. This segment provides drug manufacturers with process development expertise and technologies, such as continuous bioprocessing; testing kits and services; reagents and services; testing solutions that analyze air, water, and soil; and testing a... [Read more]

Industry Pharmaceutical Preparations
Founded 1668
Employees 59,020
Stock Exchange London Stock Exchange
Ticker Symbol 0O14
Full Company Profile

Financial Performance

In 2024, Merck KGaA's revenue was 21.16 billion, an increase of 0.78% compared to the previous year's 20.99 billion. Earnings were 2.78 billion, a decrease of -1.66%.

Financial numbers in EUR Financial Statements

News

There is no news available yet.